{
    "organizations": [],
    "uuid": "61fdcaa256e387e19774f21f97730f4a7ebc3c06",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-revive-therapeutics-advances-resea/brief-revive-therapeutics-advances-research-program-of-cannabinoid-based-therapies-targeting-liver-diseases-idUSFWN1PP0SY",
    "ord_in_thread": 0,
    "title": "BRIEF-Revive Therapeutics Advances Research Program Of Cannabinoid-Based Therapies Targeting Liver Diseases",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Revive Therapeutics Ltd:\n* REVIVE THERAPEUTICS ADVANCES RESEARCH PROGRAM OF CANNABINOID-BASED THERAPIES TARGETING LIVER DISEASES\n* REVIVE THERAPEUTICS LTD - RESEARCH WILL BE OVERSEEN BY SANYAL BIOTECHNOLOGY LLC COMPANYâ€˜S STRATEGIC RESEARCH PARTNER FOR LIVER DISEASES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T20:04:00.000+02:00",
    "crawled": "2018-01-31T16:33:52.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "revive",
        "therapeutic",
        "ltd",
        "revive",
        "therapeutic",
        "advance",
        "research",
        "program",
        "therapy",
        "targeting",
        "liver",
        "disease",
        "revive",
        "therapeutic",
        "ltd",
        "research",
        "overseen",
        "sanyal",
        "biotechnology",
        "llc",
        "company",
        "strategic",
        "research",
        "partner",
        "liver",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}